Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil

This study aimed to analyze human immunodeficiency virus (HIV) mutation profiles related to antiretroviral resistance following therapeutic failure, and the distribution of hiv subtypes in the Northeast Region of Brazil. A total of 576 blood samples from AIDS patients presenting therapeutic failure between 2002 and 2004 were analyzed. The genotyping kit viroSeq® was used to perform viral amplification in order to identify mutations related to hiv pol gene resistance. An index of 91.1% of the patients presented mutations for nucleoside reverse transcriptase inhibitors (nrti), 58.7% for non-nucleoside reverse transcriptase inhibitors (nnrti), and 94.8% for protease inhibitors (pi). The most prevalent mutations were 184V and 215E for nrti, 103N and 190A for nnrti. Most mutations associated with PIs were secondary, but significant frequencies were observed in codons 90 (25.2%), 82 (21.1%), and 30 (16.2%). The resistance index to one class of antiretrovirals was 14%, to two classes of antiretrovirals 61%, and to three classes 18.9%. Subtype B was the most prevalent (82.4%) followed by subtype F (11.8%). The prevalence of mutations related to nrti and nnrti was the same in the two subtypes, but codon analysis related to PI showed a higher frequency of mutations in codon 63 in subtype B and in codon 36 in subtype F. The present study showed that there was a high frequency of primary mutations, which offered resistance to nrti and nnrti. Monitoring patients with treatment failure is an important tool for aiding physicians in rescue therapy.

Saved in:
Bibliographic Details
Main Authors: Cavalcanti,Ana Maria Salustiano, Lacerda,Heloisa Ramos, Brito,Ana Maria de, Pereira,Sirleide, Medeiros,Daniela, Oliveira,Suelene
Format: Digital revista
Language:English
Published: Instituto Oswaldo Cruz, Ministério da Saúde 2007
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000700002
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0074-02762007000700002
record_format ojs
spelling oai:scielo:S0074-027620070007000022008-02-25Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of BrazilCavalcanti,Ana Maria SalustianoLacerda,Heloisa RamosBrito,Ana Maria dePereira,SirleideMedeiros,DanielaOliveira,Suelene human immunodeficiency virus type 1 resistance to drugs genotyping subtypes Brazil This study aimed to analyze human immunodeficiency virus (HIV) mutation profiles related to antiretroviral resistance following therapeutic failure, and the distribution of hiv subtypes in the Northeast Region of Brazil. A total of 576 blood samples from AIDS patients presenting therapeutic failure between 2002 and 2004 were analyzed. The genotyping kit viroSeq® was used to perform viral amplification in order to identify mutations related to hiv pol gene resistance. An index of 91.1% of the patients presented mutations for nucleoside reverse transcriptase inhibitors (nrti), 58.7% for non-nucleoside reverse transcriptase inhibitors (nnrti), and 94.8% for protease inhibitors (pi). The most prevalent mutations were 184V and 215E for nrti, 103N and 190A for nnrti. Most mutations associated with PIs were secondary, but significant frequencies were observed in codons 90 (25.2%), 82 (21.1%), and 30 (16.2%). The resistance index to one class of antiretrovirals was 14%, to two classes of antiretrovirals 61%, and to three classes 18.9%. Subtype B was the most prevalent (82.4%) followed by subtype F (11.8%). The prevalence of mutations related to nrti and nnrti was the same in the two subtypes, but codon analysis related to PI showed a higher frequency of mutations in codon 63 in subtype B and in codon 36 in subtype F. The present study showed that there was a high frequency of primary mutations, which offered resistance to nrti and nnrti. Monitoring patients with treatment failure is an important tool for aiding physicians in rescue therapy.info:eu-repo/semantics/openAccessInstituto Oswaldo Cruz, Ministério da SaúdeMemórias do Instituto Oswaldo Cruz v.102 n.7 20072007-11-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000700002en10.1590/S0074-02762007005000109
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Cavalcanti,Ana Maria Salustiano
Lacerda,Heloisa Ramos
Brito,Ana Maria de
Pereira,Sirleide
Medeiros,Daniela
Oliveira,Suelene
spellingShingle Cavalcanti,Ana Maria Salustiano
Lacerda,Heloisa Ramos
Brito,Ana Maria de
Pereira,Sirleide
Medeiros,Daniela
Oliveira,Suelene
Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
author_facet Cavalcanti,Ana Maria Salustiano
Lacerda,Heloisa Ramos
Brito,Ana Maria de
Pereira,Sirleide
Medeiros,Daniela
Oliveira,Suelene
author_sort Cavalcanti,Ana Maria Salustiano
title Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
title_short Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
title_full Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
title_fullStr Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
title_full_unstemmed Antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the Northeast Region of Brazil
title_sort antiretroviral resistance in individuals presenting therapeutic failure and subtypes of the human immunodeficiency virus type 1 in the northeast region of brazil
description This study aimed to analyze human immunodeficiency virus (HIV) mutation profiles related to antiretroviral resistance following therapeutic failure, and the distribution of hiv subtypes in the Northeast Region of Brazil. A total of 576 blood samples from AIDS patients presenting therapeutic failure between 2002 and 2004 were analyzed. The genotyping kit viroSeq® was used to perform viral amplification in order to identify mutations related to hiv pol gene resistance. An index of 91.1% of the patients presented mutations for nucleoside reverse transcriptase inhibitors (nrti), 58.7% for non-nucleoside reverse transcriptase inhibitors (nnrti), and 94.8% for protease inhibitors (pi). The most prevalent mutations were 184V and 215E for nrti, 103N and 190A for nnrti. Most mutations associated with PIs were secondary, but significant frequencies were observed in codons 90 (25.2%), 82 (21.1%), and 30 (16.2%). The resistance index to one class of antiretrovirals was 14%, to two classes of antiretrovirals 61%, and to three classes 18.9%. Subtype B was the most prevalent (82.4%) followed by subtype F (11.8%). The prevalence of mutations related to nrti and nnrti was the same in the two subtypes, but codon analysis related to PI showed a higher frequency of mutations in codon 63 in subtype B and in codon 36 in subtype F. The present study showed that there was a high frequency of primary mutations, which offered resistance to nrti and nnrti. Monitoring patients with treatment failure is an important tool for aiding physicians in rescue therapy.
publisher Instituto Oswaldo Cruz, Ministério da Saúde
publishDate 2007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0074-02762007000700002
work_keys_str_mv AT cavalcantianamariasalustiano antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
AT lacerdaheloisaramos antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
AT britoanamariade antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
AT pereirasirleide antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
AT medeirosdaniela antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
AT oliveirasuelene antiretroviralresistanceinindividualspresentingtherapeuticfailureandsubtypesofthehumanimmunodeficiencyvirustype1inthenortheastregionofbrazil
_version_ 1756383594137255936